Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Amlitelimab (Anti-TNFSF4 / OX40L / CD252) For research use only.
Not for use in humans.

Amlitelimab (Anti-TNFSF4 / OX40L / CD252)

Synonyms: KY1005, SAR445229

Amlitelimab (Anti-TNFSF4 / OX40L / CD252) is a nondepleting IgG4 human anti-OX40L monoclonal antibody with the potential to treat atopic dermatitis. MW: 145.94 kD.

Amlitelimab (Anti-TNFSF4 / OX40L / CD252)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Amlitelimab (Anti-TNFSF4 / OX40L / CD252) is a nondepleting IgG4 human anti-OX40L monoclonal antibody with the potential to treat atopic dermatitis. MW: 145.94 kD.

Product Details

CAS No. 2378692-15-8
Molecular Weight 145.94
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Amlitelimab (Anti-TNFSF4 / OX40L / CD252) | Amlitelimab (Anti-TNFSF4 / OX40L / CD252) supplier | purchase Amlitelimab (Anti-TNFSF4 / OX40L / CD252) | Amlitelimab (Anti-TNFSF4 / OX40L / CD252) cost | Amlitelimab (Anti-TNFSF4 / OX40L / CD252) manufacturer | order Amlitelimab (Anti-TNFSF4 / OX40L / CD252) | Amlitelimab (Anti-TNFSF4 / OX40L / CD252) distributor